Last reviewed · How we verify

NCT06040034

Bolus vs. Continuous IV Lidocaine Against Post-Extubation Cough in Post-Thyroidectomy Patients

Completed Phase 2 Last updated 22 September 2023
What this trial tests

Phase 2 trial testing Lidocaine IV in Cough in 40 participants. Completed in 1 May 2023.

Timeline
2 February 2023
Primary endpoint
1 May 2023
1 May 2023

Quick facts

Lead sponsorUniversitas Padjadjaran
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date2 February 2023
Primary completion1 May 2023
Estimated completion1 May 2023
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Universitas Padjadjaran — full company profile →

Who can join

Adults 18 to 50, any sex, with Cough. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomized controlled trial is to compare the effect of lidocaine bolus intravenous administration to lidocaine continuous intravenous administration in post thyroidectomy patients to observe the effect against post-extubation cough. The main questions it aims to answer are: * Cough incidence on both groups * Which method is preferable to reduce post-extubation cough incidence

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lidocaine IV

Trials testing the same drug.

Other recruiting trials for Cough

Currently open trials in the same condition.

Other Universitas Padjadjaran trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06040034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing